PTPN2 loss-of function mutations occur in 7% of patients with T-ALL and, consequently, in these cases, T-ALL cells were more sensitive to cytokine stimulation, resulting in enhanced activation of JAK-STAT cytokine receptor pathways [98]. This evidence concerns the gene PTPN2 and acute lymphoblastic leukemia.